FOXC2 and neoplasm: Among the 62 tumor samples, the proportion of FOXC2-positive cells was significantly (p = 0.0005) for T3-T4 tumors (94.9%; 37 of 39) than for T1-T2 samples (56.5%; 13 of 23).